Synairgen Share Price (SNG)

16.75 0.00 (0.00%) delayed: 6:04PM BST
Bid price 16.50 Open price 16.50
Ask price 17.00 Prev close 16.75
High price 16.50 Spread 2.94%
Low price 16.50 Volume 14,000

Register now for FREE live Synairgen share prices, Synairgen stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Synairgen Level 2 Data, indepth research tools and investor commentary for Synairgen (SNG) and other London Stock Exchange equities.

Synairgen Share Price Chart

Advanced Charts >>

Register now for FREE Synairgen share price charts

Synairgen Share Price Information

Name Synairgen Epic SNG
Sector Pharmaceuticals & Biotechnology ISIN GB00B0381Z20
Activites Synairgen plc was founded by Professors Stephen Holgate, Donna Davies and Ratko Djukanovic, a world-renowned respiratory research team from the University of Southampton, and spun-out from the University in June 2003. Synairgen seeks to commercialise a number of drug discovery opportunities, through its own internal research programmes and those that have been carefully selected from the wider range of research projects led by the Founders in their academic roles, and which offer out-licensing opportunities. The Group intends to out-license its IP at an early stage (pre-Phase II) rather than committing significant capital resources to late-stage clinical trials. Since June 2003, the Company has made significant progress: two proprietary programmes in the field of asthma have been initiated and the Company has signed four agreements with pharmaceutical and biotechnology companies, including Merck Frosst (affiliate of Merck & Co Inc), Cambridge Antibody Technology and Centocor Inc (part of Johnson and Johnson). Synairgen is currently discussing further collaboration agreements. Index n/a

Synairgen Key Numbers

Latest Share Price (p) 16.75 Net Gearing (%) -48.84
Market Capitalisation (£m) 18.06 Gross Gearing (%) 14.40
Shares in issue (m) 109.43 Debt Ratio 0.00
P/E Ratio 8.55 Debt-to-Equity Ratio 0.00
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.17
Dividend Yield (%) 0.00 Price to book value 2.75
Dividend cover (x) 0.00 ROCE (%) 24.85
Earning per share (p) 1.93 EPS Growth (%) 162.66
52 week high / low 26.50 / 10.75 DPS Growth (%) n/a

Synairgen Director Deals

Dec.Date Type Director Pos No. of Shares
12/10/2018 PLAC Richard Marsden MD 156,250
12/10/2018 PLAC Phillip Monk ED 46,875
12/10/2018 PLAC John Ward FD 62,500
12/11/2015 BUY Richard Marsden MD 43,460
12/11/2015 BUY Phillip Monk ED 21,729

More Synairgen Director Deals >>

Synairgen Company News

15:01 16/10/2018

Holding(s) in Company

RNS Number : 2367E Synairgen plc 16 October 2018   TR-1: S tandard form for notification of major holdings   NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i...

08:49 15/10/2018

Holding(s) in Company

RNS Number : 0227E Synairgen plc 15 October 2018       Synairgen plc ('Synairgen' or the 'Company')   Holding in Company Southampton, UK, : Synairgen plc (LSE: SNG), the respiratory drug discovery and development company, announces that it was today...

11:40 12/10/2018

Director Deals - Synairgen PLC (SNG)

John Ward, Financial Director, 62,500 shares in the company on the 12th October 2018 at a price of 16.00p. The Director now holds 399,006 shares. Story provided by Director deals data provided by

More Synairgen Company News >>

Register now for FREE Synairgen company news

Synairgen Share Price Discussions

more than 1 year ago

Synairgen (SNG)

Synairgen is a drug discovery and development company founded by University of Southampton Professors Stephen Holgate, Donna Davies and Ratko Djukanovic. The business, focused primarily on severe asthma and COPD, uses its differentiating human biology BioBank platform and world-renowned...

Register now for FREE Synairgen share price discussions